MINI FUTURE LONG - STRYKER CORP. Stock

Certificat

DE000PD5W5X6

Real-time Bid/Ask 07:24:11 2024-04-30 EDT
15.15 EUR / 15.3 EUR +0.43% Intraday chart for MINI FUTURE LONG - STRYKER CORP.
Current month-10.51%
1 month-10.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-04-30 15.16 0.00% 0
24-04-29 15.16 +1.54% 0
24-04-26 14.93 -0.80% 0
24-04-25 15.05 0.00% 0
24-04-24 15.05 +1.76% 0

Delayed Quote Börse Stuttgart

Last update April 30, 2024 at 05:47 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD5W5X
ISINDE000PD5W5X6
Date issued 2022-05-12
Strike 176.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 7.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.08
Lowest since issue 3.45
Spread 0.15
Spread %0.98%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
338.9 USD
Average target price
365.7 USD
Spread / Average Target
+7.91%
Consensus